Callable Multi Barrier Reverse Convertible

Symbol: MAREJB
ISIN: CH1498421200
Issuer:
Bank Julius Bär
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.
Price Time-delayed price
13.05.26
17:53:39
- %
100.00 %
CHF
Volume
0
20,000
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 93.40
Diff. absolute / % -2.45 -2.56%

Determined prices

Last Price 91.45 Volume 10,000
Time 14:54:01 Date 30/04/2026

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1498421200
Valor 149842120
Symbol MAREJB
Quotation in percent Yes
Coupon p.a. 21.02%
Coupon Premium 21.02%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
Exercise type American
Currency Swiss Franc
First Trading Date 16/02/2026
Date of maturity 16/02/2027
Last trading day 09/02/2027
Settlement Type Path-dependent
IRS 871m Not applicable
Currency safeguarded Yes
Pricing Clean
Issuer Bank Julius Bär

Key data

Ask Price (basis for calculation) 100.0000
Maximum yield 15.25%
Maximum yield p.a. 20.02%
Sideways yield 15.25%
Sideways yield p.a. 20.02%

market maker quality Date: 12/05/2026

Average Spread 0.78%
Last Best Bid Price 95.85 %
Last Best Ask Price 96.60 %
Last Best Bid Volume 500,000
Last Best Ask Volume 500,000
Average Buy Volume 500,000
Average Sell Volume 500,000
Average Buy Value 476,103 CHF
Average Sell Value 479,853 CHF
Spreads Availability Ratio 99.45%
Quote Availability 99.45%

Underlyings

Name Carl Zeiss Meditec AG Gerresheimer AG
ISIN DE0005313704 DE000A0LD6E6
Price 24.71 EUR 25.20 EUR
Date 14/05/26 18:20 14/05/26 18:20
Cap 27.90 EUR 26.64 EUR
Distance to Cap -2.7 -1.7
Distance to Cap in % -10.71% -6.82%
Is Cap Level reached No No
Barrier 13.95 EUR 13.32 EUR
Distance to Barrier 11.25 11.62
Distance to Barrier in % 44.64% 46.59%
Is Barrier reached No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.